Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ...
Fourth Quarter 2025 Revenue of $1.5 Million, a 92% Increase Compared to Prior Year ~~ Record Full Year 2025 Revenue of $3.9 Million, a 20% Increase compared to Prior Year, Driven by Strong Second Half ...
The commentary titled ‘Establishing a Commercial Solution for Extremely Rare Genetic Diseases’ was published in Nature BiotechnologyCommentary coincides with draft guidance from the FDA outlining a ...
ReNeuron Group Limited, a leading UK biotechnology company, has joined Swansea University’s Institute of Life Science (ILS) in a new strategic research partnership to advance next-generation exosome ...
Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of ...
VANCOUVER, BC – 19th March, 2026 – Ondine Biomedical Inc. (LON: OBI) reports that its North American Phase 3 LANTERN pivotal study has reached over 93% enrolment. This major milestone brings the ...
Clinical research organization uses AI agent-driven knowledge platform built on a unified contextual data layer to identify higher-performing trial sites faster and minimize inclusion of costly ...
Kupando raised an additional €10 million in Series A financing, bringing the total Series A funding to €23 million.Investment again led by Remiges Ventures, co-led by LifeCare Partners, with ...
Biotium's New Cell Barcoding Kit Streamlines Flow Cytometry with 15-Sample, Single-Tube Multiplexing
ViaPlex™ enables fluorescent barcoding of up to 15 cell populations in a single tube to reduce reagent use, save time, and increase throughput for flow cytometry workflows.FREMONT, CA, March 19, 2026 ...
Gene and cell therapy is moving fast – and in a clear direction. Programs are pushing toward more complex payloads, virus-free engineering, and manufacturing models that can scale from early research ...
Lund, Sweden – Manje Health has been selected to join the prestigious Mastercard Lighthouse MASSIV Programme, a leading initiative supporting fintech companies with solutions that create societal ...
March 2026- Poolbeg Pharma (AIM: POLB, 'Poolbeg' or the 'Company'), a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field, announces the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results